SCHEMBL6598152

SCHEMBL6598152

CC(C)(C)OC(=O)N(OC(=O)Nc1cnccc1C#CCO)c1cnccc1C#CCN1CCCC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.33
GPR119 Q8TDV5 2/20 0.32
PLK4 O00444 1/20 0.31
AURKA O14965 1/20 0.31
MAPK13 O15264 1/20 0.31
PDPK1 O15530 1/20 0.31
DYRK3 O43781 1/20 0.31
ROCK2 O75116 1/20 0.31
RPS6KA5 O75582 1/20 0.31
RPS6KA4 O75676 1/20 0.31
PRKD3 O94806 1/20 0.31
MAP4K4 O95819 1/20 0.31
ABL1 P00519 1/20 0.31
INSR P06213 1/20 0.31
LCK P06239 1/20 0.31
FYN P06241 1/20 0.31
CSF1R P07333 1/20 0.31
LYN P07948 1/20 0.31
RET P07949 1/20 0.31
MET P08581 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6595160 0.75 GPR119 (0.34) GPR119GSK3BNAMPT
SCHEMBL6034128 0.73 KDM4E (0.41) PIK3CAPLK4AURKAMAPK13PDPK1
SCHEMBL6035359 0.72 ALDH1A1 (0.36) PIK3CAPLK4AURKAMAPK13PDPK1
SCHEMBL6035878 0.69 NAMPT (0.41) NAMPT
SCHEMBL6035364 0.68 ALDH1A1 (0.32)
SCHEMBL6034734 0.65 MELK (0.40) MELKKDM4E
SCHEMBL6035419 0.65 ACHE (0.46) NAMPT
SCHEMBL6607970 0.65 NAMPT (0.38) NAMPT
SCHEMBL6595468 0.64 ACHE (0.42) GPR119GSK3BNAMPT
SCHEMBL6604921 0.64 CYP17A1 (0.32) GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1414801-A1 ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 AstraZeneca AB (SE) 2004-05-06 EP disclosed
WO-2003004472-A1 ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 ASTRAZENECA AB (SE) 2003-01-16 WO disclosed